Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin-Bing S Zhou

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|December 31, 2005
Targeting ligand cleavage to inhibit the ErbB pathway in cancerBin-Bing S Zhou
Progress in Cell Cycle Research|November 5, 2003
Drug discovery targeting Chk1 and Chk2 kinasesBin-Bing S Zhou, Edward A Sausville
Cancer Biology & Therapy|September 26, 2003
Targeting DNA checkpoint kinases in cancer therapyBin-Bing S Zhou, Hilary J Anderson, Michel Roberge
DNA Repair|October 25, 2025
DNA damage response and its clinical implications in pediatric cancersYiyan Zhang, Jiyuan Teng, Xiaolong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repairEmma Bolderson, Derek J Richard, Bin-Bing S Zhou, et al.
Oncotarget|February 9, 2018
HPRT1 activity loss is associated with resistance to thiopurine in ALLFan Yang, Houshun Fang, Dan Wang, et al.
Frontiers in Pharmacology|January 23, 2024
Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cellsYao Chen, Houshun Fang, Huiying Sun, et al.
Nature Reviews. Drug Discovery|October 2, 2009
Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryBin-Bing S Zhou, Haiying Zhang, Marc Damelin, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
ADAM proteases, ErbB pathways and cancerBin-Bing S Zhou, Jordan S Fridman, Xiangdong Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2019
AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cellsLijuan Du, Fan Yang, Houshun Fang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|December 31, 2005
Targeting ligand cleavage to inhibit the ErbB pathway in cancerBin-Bing S Zhou
Progress in Cell Cycle Research|November 5, 2003
Drug discovery targeting Chk1 and Chk2 kinasesBin-Bing S Zhou, Edward A Sausville
Cancer Biology & Therapy|September 26, 2003
Targeting DNA checkpoint kinases in cancer therapyBin-Bing S Zhou, Hilary J Anderson, Michel Roberge
DNA Repair|October 25, 2025
DNA damage response and its clinical implications in pediatric cancersYiyan Zhang, Jiyuan Teng, Xiaolong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repairEmma Bolderson, Derek J Richard, Bin-Bing S Zhou, et al.
Oncotarget|February 9, 2018
HPRT1 activity loss is associated with resistance to thiopurine in ALLFan Yang, Houshun Fang, Dan Wang, et al.
Frontiers in Pharmacology|January 23, 2024
Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cellsYao Chen, Houshun Fang, Huiying Sun, et al.
Nature Reviews. Drug Discovery|October 2, 2009
Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryBin-Bing S Zhou, Haiying Zhang, Marc Damelin, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
ADAM proteases, ErbB pathways and cancerBin-Bing S Zhou, Jordan S Fridman, Xiangdong Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2019
AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cellsLijuan Du, Fan Yang, Houshun Fang, et al.
Pageof 4